Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells therapy(Dana-Farber Cancer Institute)

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameCytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells therapy(Dana-Farber Cancer Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer InstituteImmunitybio Inc
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesOvarian Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A